While North America remains the leader in delirium research spending, the Delirium Market region focus is shifting toward Japan and Western Europe. In 2026, Japan’s "Super-Aged" status means that over 30% of their hospital beds are occupied by patients at high risk for delirium. This has led to the world’s first national "Delirium Prevention Mandate." In emerging markets like Brazil...